BioHealth News
Gain Therapeutics Announces Proposed Public Offering
BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery…
Read More
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy
BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of…
Read More
NOVA’s first Innovation District launches with transformational grant from GO Virginia
FOR IMMEDIATE RELEASE Manassas, Virginia - July 16, 2025 Thanks to a major investment from GO Virginia, the region’s first Innovation District is taking…
Read More
IonQ Completes Acquisition of Capella Space, Advancing Vision for Space-Based Quantum Communications
COLLEGE PARK, MD - July 15, 2025 - IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced the completion of its…
Read More
UM School of Medicine Team Wins NIH TARGETED Challenge with Brain Genome Editing Technology
July 14, 2025 | Jon Kelvey - A team of researchers from the University of Maryland School of Medicine (UMSOM) recently won a $250,000 prize…
Read More
Now Enrolling: Maryland Global Consulting Program Relaunches This Fall
Maryland companies looking to expand their global reach can now apply for the Maryland Global Consulting Program, returning this fall with a new cohort…
Read More
Endpoint News: Biotech’s Q2 numbers paint a picture of the good, the bad and the ugly
By John Carroll, Editor & Founder - The numbers aren’t all bad in biotech. But you’d be forgiven if you thought they were. And you’d…
Read More
NSF advances 29 semifinalists in the second NSF Regional Innovation Engines competition
July 8, 2025 - The U.S. National Science Foundation Regional Innovation Engines (NSF Engines) program announced the 29 semifinalists advancing to the next stage of the second…
Read More
Top Innovators Wanted! APPLY NOW! Accelerate Investor Conference
The Accelerate Investor Conference is a venture investor and startup conference and early stage business competition that showcases our region as a powerhouse for innovation…
Read More
CEL-SCI Announces $5.7M At-the-Market Offering
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a clinical stage cancer immunotherapy company, today announced the pricing of a best-efforts…
Read More
CEL-SCI to Partner With Top Saudi Pharma on Cancer Treatment
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it has reached an agreement with one of Saudi Arabia’s premier pharmaceutical and healthcare companies for a…
Read More
ARPA-H Launches Brain Recovery Program; Proposers’ Day Registration Now Open
Today, the Advanced Research Projects Agency for Health (ARPA-H) announced its groundbreaking Functional Repair of Neocortical Tissue (FRONT) program, a transformative initiative to restore…
Read More
Previous BHCR Crab Trap Winner Nanochon Announces Health Canada Approval for First Human Investigation
Washington, DC, July 10 2025 – Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage…
Read More
Johns Hopkins’ Robot Performs First Autonomous Surgery
by Jill Rosen - A robot trained on videos of surgeries performed a lengthy phase of a gallbladder removal without human help. The robot operated…
Read More
BioBytes Episode 34: How to Launch a Biotech Startup in 2025 | Real Talk with Richard Bendis
Getting a biotech company off the ground takes more than science; it takes strategy, funding, and the right network. In this episode, I’m joined…
Read More